Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucosal immunity and vaccination.

J Holmgren1

  • 1Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.

FEMS Microbiology Immunology
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Developing effective mucosal vaccines requires understanding local immune responses. Enhancing antigen delivery and identifying adjuvants are key to improving oral vaccine strategies against enteric and other mucosal infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemical modification of cholera toxin for characterization of antigenic receptor-binding and toxic sites.

FEBS letters·2017
Same author

Lack of Fc Gamma Receptor IIIA Promotes Rather than Suppresses Humoral and Cellular Immune Responses after Mucosal or Parenteral Immunization with Antigen and Adjuvants.

Scandinavian journal of immunology·2017
Same author

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.

Vaccine·2013
Same author

Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein.

Vaccine·2013
Same author

Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.

Mucosal immunology·2012
Same author

Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues.

Current topics in microbiology and immunology·2010
Same journal

A comparison of the different methods available for determining BCG-macrophage interactions in vitro, including a new method of colony counting in broth.

FEMS microbiology immunology·1992
Same journal

Cell-stroma interactions in monocytopoiesis.

FEMS microbiology immunology·1992
Same journal

Effect of blocking TNF-alpha on intracellular BCG (Bacillus Calmette Guerin) growth in human monocyte-derived macrophages.

FEMS microbiology immunology·1992
Same journal

The development of a radiometric assay for monocyte phagocytosis and killing.

FEMS microbiology immunology·1992
Same journal

Use of enzyme microassay to detect eosinophil potentiating activity of cytokines in sheep.

FEMS microbiology immunology·1992
Same journal

Heterogeneity of peripheral blood monocyte populations in human immunodeficiency virus-1 seropositive patients.

FEMS microbiology immunology·1992
See all related articles

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • The gut mucosal immune system is crucial for defending against pathogens causing diarrhoeal disease.
  • Inducing protective local immune responses at mucosal sites remains a challenge in vaccine development.
  • Secretory IgA (SIgA) is vital for mucosal immunity, offering protection against various infections.

Purpose of the Study:

  • To review the current understanding of mucosal immunity and its application in vaccine development.
  • To discuss strategies for enhancing antigen delivery and identifying adjuvants for mucosal vaccines.
  • To explore the potential of oral vaccines against enteric, respiratory, and urogenital tract infections.

Main Methods:

  • Review of existing literature on mucosal immunity, SIgA, and vaccine development.

Related Experiment Videos

  • Discussion of the common mucosal immune system concept.
  • Analysis of challenges and opportunities in developing effective mucosal vaccines.

    • Main Results:

    • An effective oral cholera vaccine demonstrates the potential of SIgA-inducing vaccines.
    • Oral vaccine development for other enteric pathogens like E. coli, Shigella, and rotaviruses is ongoing.
    • The common mucosal immune system offers possibilities for developing vaccines against non-enteric infections.

    Conclusions:

    • Overcoming challenges in antigen delivery and adjuvant identification is critical for practical mucosal vaccination.
    • Further research into mucosal immunity is essential for advancing vaccine development against a range of infectious diseases.
    • Optimizing mucosal vaccine strategies holds promise for improved global health outcomes.